Prevalence and burden of bipolar disorders in European countries
A literature search, supplemented by an expert survey and selected reanalyses of existing data from epidemiological studies was performed to determine the prevalence and associated burden of bipolar I and II disorder in EU countries. Only studies using established diagnostic instruments based on DSM...
Gespeichert in:
Veröffentlicht in: | European neuropsychopharmacology 2005-08, Vol.15 (4), p.425-434 |
---|---|
Hauptverfasser: | , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 434 |
---|---|
container_issue | 4 |
container_start_page | 425 |
container_title | European neuropsychopharmacology |
container_volume | 15 |
creator | Pini, Stefano de Queiroz, Valéria Pagnin, Daniel Pezawas, Lukas Angst, Jules Cassano, Giovanni B. Wittchen, Hans-Ulrich |
description | A literature search, supplemented by an expert survey and selected reanalyses of existing data from epidemiological studies was performed to determine the prevalence and associated burden of bipolar I and II disorder in EU countries. Only studies using established diagnostic instruments based on DSM-III-R or DSM-IV, or ICD-10 criteria were considered. Fourteen studies from a total of 10 countries were identified. The majority of studies reported 12-month estimates of approximately 1% (range 0.5–1.1%), with little evidence of a gender difference. The cumulative lifetime incidence (two prospective-longitudinal studies) is slightly higher (1.5–2%); and when the wider range of bipolar spectrum disorders is considered estimates increased to approximately 6%. Few studies have reported separate estimates for bipolar I and II disorders. Age of first onset of bipolar disorder is most frequently reported in late adolescence and early adulthood. A high degree of concurrent and sequential comorbidity with other mental disorders and physical illnesses is common. Most studies suggest equally high or even higher levels of impairments and disabilities of bipolar disorders as compared to major depression and schizophrenia. Few data are available on treatment and health care utilization. |
doi_str_mv | 10.1016/j.euroneuro.2005.04.011 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_68021230</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0924977X0500074X</els_id><sourcerecordid>68021230</sourcerecordid><originalsourceid>FETCH-LOGICAL-c472t-b4deacafcf3fca1036f8cd9aa081eb163281abfb6a1ed09db36da1e82b1e366e3</originalsourceid><addsrcrecordid>eNqFkE1Lw0AQhhdRbK3-Bc3JW-J-JJvkZpH6AQU9KHhb9mMWtqTZupsU_PduaNGjl5lheN95mQehG4ILggm_2xQwBt9PpaAYVwUuC0zICZqTpmZ53XB6iua4pWXe1vXnDF3EuMGYVIy152hGqpZVnLI5un8LsJcd9Boy2ZtMjcFAn3mbKbfznQyZcdGnXYiZ67NVCtyB7DPtx34IDuIlOrOyi3B17Av08bh6f3jO169PLw_Lda7Lmg65Kg1ILa22zGpJMOO20aaVEjcEFOGMNkQqq7gkYHBrFOMmjQ1VBBjnwBbo9nB3F_zXCHEQWxc1dJ3swY9R8AZTQhlOwvog1MHHGMCKXXBbGb4FwWKCJzbiF56Y4AlcigQvOa-PEaPagvnzHWklwfIggPTo3kEQUbsJnXEB9CCMd_-G_ACJIYcJ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>68021230</pqid></control><display><type>article</type><title>Prevalence and burden of bipolar disorders in European countries</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Pini, Stefano ; de Queiroz, Valéria ; Pagnin, Daniel ; Pezawas, Lukas ; Angst, Jules ; Cassano, Giovanni B. ; Wittchen, Hans-Ulrich</creator><creatorcontrib>Pini, Stefano ; de Queiroz, Valéria ; Pagnin, Daniel ; Pezawas, Lukas ; Angst, Jules ; Cassano, Giovanni B. ; Wittchen, Hans-Ulrich</creatorcontrib><description>A literature search, supplemented by an expert survey and selected reanalyses of existing data from epidemiological studies was performed to determine the prevalence and associated burden of bipolar I and II disorder in EU countries. Only studies using established diagnostic instruments based on DSM-III-R or DSM-IV, or ICD-10 criteria were considered. Fourteen studies from a total of 10 countries were identified. The majority of studies reported 12-month estimates of approximately 1% (range 0.5–1.1%), with little evidence of a gender difference. The cumulative lifetime incidence (two prospective-longitudinal studies) is slightly higher (1.5–2%); and when the wider range of bipolar spectrum disorders is considered estimates increased to approximately 6%. Few studies have reported separate estimates for bipolar I and II disorders. Age of first onset of bipolar disorder is most frequently reported in late adolescence and early adulthood. A high degree of concurrent and sequential comorbidity with other mental disorders and physical illnesses is common. Most studies suggest equally high or even higher levels of impairments and disabilities of bipolar disorders as compared to major depression and schizophrenia. Few data are available on treatment and health care utilization.</description><identifier>ISSN: 0924-977X</identifier><identifier>EISSN: 1873-7862</identifier><identifier>DOI: 10.1016/j.euroneuro.2005.04.011</identifier><identifier>PMID: 15935623</identifier><language>eng</language><publisher>Netherlands: Elsevier B.V</publisher><subject>Age Factors ; Age of Onset ; Bipolar disorder ; Bipolar Disorder - complications ; Bipolar Disorder - economics ; Bipolar Disorder - epidemiology ; Burden ; Comorbidity ; Cost of Illness ; Depression ; Disability Evaluation ; Epidemiologic Studies ; Europe - epidemiology ; Female ; Humans ; Hypomania ; Incidence ; Male ; Mania ; MEDLINE ; Personality Inventory ; Prevalence ; Primary Health Care ; Psychiatric Status Rating Scales ; Risk Factors</subject><ispartof>European neuropsychopharmacology, 2005-08, Vol.15 (4), p.425-434</ispartof><rights>2005 Elsevier B.V. and ECNP</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c472t-b4deacafcf3fca1036f8cd9aa081eb163281abfb6a1ed09db36da1e82b1e366e3</citedby><cites>FETCH-LOGICAL-c472t-b4deacafcf3fca1036f8cd9aa081eb163281abfb6a1ed09db36da1e82b1e366e3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0924977X0500074X$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65306</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/15935623$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Pini, Stefano</creatorcontrib><creatorcontrib>de Queiroz, Valéria</creatorcontrib><creatorcontrib>Pagnin, Daniel</creatorcontrib><creatorcontrib>Pezawas, Lukas</creatorcontrib><creatorcontrib>Angst, Jules</creatorcontrib><creatorcontrib>Cassano, Giovanni B.</creatorcontrib><creatorcontrib>Wittchen, Hans-Ulrich</creatorcontrib><title>Prevalence and burden of bipolar disorders in European countries</title><title>European neuropsychopharmacology</title><addtitle>Eur Neuropsychopharmacol</addtitle><description>A literature search, supplemented by an expert survey and selected reanalyses of existing data from epidemiological studies was performed to determine the prevalence and associated burden of bipolar I and II disorder in EU countries. Only studies using established diagnostic instruments based on DSM-III-R or DSM-IV, or ICD-10 criteria were considered. Fourteen studies from a total of 10 countries were identified. The majority of studies reported 12-month estimates of approximately 1% (range 0.5–1.1%), with little evidence of a gender difference. The cumulative lifetime incidence (two prospective-longitudinal studies) is slightly higher (1.5–2%); and when the wider range of bipolar spectrum disorders is considered estimates increased to approximately 6%. Few studies have reported separate estimates for bipolar I and II disorders. Age of first onset of bipolar disorder is most frequently reported in late adolescence and early adulthood. A high degree of concurrent and sequential comorbidity with other mental disorders and physical illnesses is common. Most studies suggest equally high or even higher levels of impairments and disabilities of bipolar disorders as compared to major depression and schizophrenia. Few data are available on treatment and health care utilization.</description><subject>Age Factors</subject><subject>Age of Onset</subject><subject>Bipolar disorder</subject><subject>Bipolar Disorder - complications</subject><subject>Bipolar Disorder - economics</subject><subject>Bipolar Disorder - epidemiology</subject><subject>Burden</subject><subject>Comorbidity</subject><subject>Cost of Illness</subject><subject>Depression</subject><subject>Disability Evaluation</subject><subject>Epidemiologic Studies</subject><subject>Europe - epidemiology</subject><subject>Female</subject><subject>Humans</subject><subject>Hypomania</subject><subject>Incidence</subject><subject>Male</subject><subject>Mania</subject><subject>MEDLINE</subject><subject>Personality Inventory</subject><subject>Prevalence</subject><subject>Primary Health Care</subject><subject>Psychiatric Status Rating Scales</subject><subject>Risk Factors</subject><issn>0924-977X</issn><issn>1873-7862</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2005</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkE1Lw0AQhhdRbK3-Bc3JW-J-JJvkZpH6AQU9KHhb9mMWtqTZupsU_PduaNGjl5lheN95mQehG4ILggm_2xQwBt9PpaAYVwUuC0zICZqTpmZ53XB6iua4pWXe1vXnDF3EuMGYVIy152hGqpZVnLI5un8LsJcd9Boy2ZtMjcFAn3mbKbfznQyZcdGnXYiZ67NVCtyB7DPtx34IDuIlOrOyi3B17Av08bh6f3jO169PLw_Lda7Lmg65Kg1ILa22zGpJMOO20aaVEjcEFOGMNkQqq7gkYHBrFOMmjQ1VBBjnwBbo9nB3F_zXCHEQWxc1dJ3swY9R8AZTQhlOwvog1MHHGMCKXXBbGb4FwWKCJzbiF56Y4AlcigQvOa-PEaPagvnzHWklwfIggPTo3kEQUbsJnXEB9CCMd_-G_ACJIYcJ</recordid><startdate>20050801</startdate><enddate>20050801</enddate><creator>Pini, Stefano</creator><creator>de Queiroz, Valéria</creator><creator>Pagnin, Daniel</creator><creator>Pezawas, Lukas</creator><creator>Angst, Jules</creator><creator>Cassano, Giovanni B.</creator><creator>Wittchen, Hans-Ulrich</creator><general>Elsevier B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20050801</creationdate><title>Prevalence and burden of bipolar disorders in European countries</title><author>Pini, Stefano ; de Queiroz, Valéria ; Pagnin, Daniel ; Pezawas, Lukas ; Angst, Jules ; Cassano, Giovanni B. ; Wittchen, Hans-Ulrich</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c472t-b4deacafcf3fca1036f8cd9aa081eb163281abfb6a1ed09db36da1e82b1e366e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2005</creationdate><topic>Age Factors</topic><topic>Age of Onset</topic><topic>Bipolar disorder</topic><topic>Bipolar Disorder - complications</topic><topic>Bipolar Disorder - economics</topic><topic>Bipolar Disorder - epidemiology</topic><topic>Burden</topic><topic>Comorbidity</topic><topic>Cost of Illness</topic><topic>Depression</topic><topic>Disability Evaluation</topic><topic>Epidemiologic Studies</topic><topic>Europe - epidemiology</topic><topic>Female</topic><topic>Humans</topic><topic>Hypomania</topic><topic>Incidence</topic><topic>Male</topic><topic>Mania</topic><topic>MEDLINE</topic><topic>Personality Inventory</topic><topic>Prevalence</topic><topic>Primary Health Care</topic><topic>Psychiatric Status Rating Scales</topic><topic>Risk Factors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Pini, Stefano</creatorcontrib><creatorcontrib>de Queiroz, Valéria</creatorcontrib><creatorcontrib>Pagnin, Daniel</creatorcontrib><creatorcontrib>Pezawas, Lukas</creatorcontrib><creatorcontrib>Angst, Jules</creatorcontrib><creatorcontrib>Cassano, Giovanni B.</creatorcontrib><creatorcontrib>Wittchen, Hans-Ulrich</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>European neuropsychopharmacology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Pini, Stefano</au><au>de Queiroz, Valéria</au><au>Pagnin, Daniel</au><au>Pezawas, Lukas</au><au>Angst, Jules</au><au>Cassano, Giovanni B.</au><au>Wittchen, Hans-Ulrich</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Prevalence and burden of bipolar disorders in European countries</atitle><jtitle>European neuropsychopharmacology</jtitle><addtitle>Eur Neuropsychopharmacol</addtitle><date>2005-08-01</date><risdate>2005</risdate><volume>15</volume><issue>4</issue><spage>425</spage><epage>434</epage><pages>425-434</pages><issn>0924-977X</issn><eissn>1873-7862</eissn><abstract>A literature search, supplemented by an expert survey and selected reanalyses of existing data from epidemiological studies was performed to determine the prevalence and associated burden of bipolar I and II disorder in EU countries. Only studies using established diagnostic instruments based on DSM-III-R or DSM-IV, or ICD-10 criteria were considered. Fourteen studies from a total of 10 countries were identified. The majority of studies reported 12-month estimates of approximately 1% (range 0.5–1.1%), with little evidence of a gender difference. The cumulative lifetime incidence (two prospective-longitudinal studies) is slightly higher (1.5–2%); and when the wider range of bipolar spectrum disorders is considered estimates increased to approximately 6%. Few studies have reported separate estimates for bipolar I and II disorders. Age of first onset of bipolar disorder is most frequently reported in late adolescence and early adulthood. A high degree of concurrent and sequential comorbidity with other mental disorders and physical illnesses is common. Most studies suggest equally high or even higher levels of impairments and disabilities of bipolar disorders as compared to major depression and schizophrenia. Few data are available on treatment and health care utilization.</abstract><cop>Netherlands</cop><pub>Elsevier B.V</pub><pmid>15935623</pmid><doi>10.1016/j.euroneuro.2005.04.011</doi><tpages>10</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0924-977X |
ispartof | European neuropsychopharmacology, 2005-08, Vol.15 (4), p.425-434 |
issn | 0924-977X 1873-7862 |
language | eng |
recordid | cdi_proquest_miscellaneous_68021230 |
source | MEDLINE; Elsevier ScienceDirect Journals |
subjects | Age Factors Age of Onset Bipolar disorder Bipolar Disorder - complications Bipolar Disorder - economics Bipolar Disorder - epidemiology Burden Comorbidity Cost of Illness Depression Disability Evaluation Epidemiologic Studies Europe - epidemiology Female Humans Hypomania Incidence Male Mania MEDLINE Personality Inventory Prevalence Primary Health Care Psychiatric Status Rating Scales Risk Factors |
title | Prevalence and burden of bipolar disorders in European countries |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-08T02%3A02%3A41IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Prevalence%20and%20burden%20of%20bipolar%20disorders%20in%20European%20countries&rft.jtitle=European%20neuropsychopharmacology&rft.au=Pini,%20Stefano&rft.date=2005-08-01&rft.volume=15&rft.issue=4&rft.spage=425&rft.epage=434&rft.pages=425-434&rft.issn=0924-977X&rft.eissn=1873-7862&rft_id=info:doi/10.1016/j.euroneuro.2005.04.011&rft_dat=%3Cproquest_cross%3E68021230%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=68021230&rft_id=info:pmid/15935623&rft_els_id=S0924977X0500074X&rfr_iscdi=true |